Skip to main content

Attovia Therapeutics, Inc.

ATTO
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0002058707

In the last 90 days, Attovia Therapeutics, Inc. insiders filed 1 open-market purchase and 1 sale; 65 institutions reported holding it in 13F filings for Q3 2026, worth $693.4M in total; no superinvestor holds it.

Source
SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
Updated
Nov 10, 2026, 1:21 AM ET

No financial statements

Attovia Therapeutics, Inc. has no annual statements on file yet. See the quarterly statements.